The Vitamin Shoppe has launched its first proprietary CBD products after first debuting the hemp-based products in its stores last year.

Mind Cure’s new CSO is a decorated researcher, entrepreneur and inventor.

Mydecine provides an update on its Phase 2A clinical trial of psilocybin-assisted psychotherapy for the treatment of PTSD.

Field Trip is entering the (already legal) Netherlands psilocybin market with a “Field Trip Health Center” in Amsterdam.

Montana made recreational cannabis legal this past election, and now, they’ve begun the process of licensing, already looking ahead to the future of the recreational industry. 

To commercialize psychedelic drugs, they first have to be legalized. In the United States, an important ally in this battle has surfaced: the DoD.

Another incremental step forward in one of MindMed’s leading psychedelics R&D initiatives.

A legal memo on cannabis legalization from an Israeli inter-ministerial committee is set to be drafted into a bill that could come to the Knesset floor for a vote before the year’s end.

Compass joins an international organization dedicated to advancing psychedelic drug research.

Mind Cure Health is seeking to raise $3 million via the sale of 6.66 million units.